Cargando…
“It wasn’t here, and now it is. It’s everywhere": fentanyl’s rising presence in Oregon’s drug supply
BACKGROUND: Illicit fentanyl has contributed to a drastic increase in overdose drug deaths. While fentanyl has subsumed the drug supply in the Northeastern and Midwestern USA, it has more recently reached the Western USA. For this study, we explored perspectives of people who use drugs (PWUD) on the...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275036/ https://www.ncbi.nlm.nih.gov/pubmed/35818072 http://dx.doi.org/10.1186/s12954-022-00659-9 |
_version_ | 1784745410064023552 |
---|---|
author | Shin, Sarah S. LaForge, Kate Stack, Erin Pope, Justine Leichtling, Gillian Larsen, Jessica E. Leahy, Judith M. Seaman, Andrew Hoover, Daniel Chisholm, Laura Blazes, Christopher Baker, Robin Byers, Mikaela Branson, Katie Korthuis, P. Todd |
author_facet | Shin, Sarah S. LaForge, Kate Stack, Erin Pope, Justine Leichtling, Gillian Larsen, Jessica E. Leahy, Judith M. Seaman, Andrew Hoover, Daniel Chisholm, Laura Blazes, Christopher Baker, Robin Byers, Mikaela Branson, Katie Korthuis, P. Todd |
author_sort | Shin, Sarah S. |
collection | PubMed |
description | BACKGROUND: Illicit fentanyl has contributed to a drastic increase in overdose drug deaths. While fentanyl has subsumed the drug supply in the Northeastern and Midwestern USA, it has more recently reached the Western USA. For this study, we explored perspectives of people who use drugs (PWUD) on the changing drug supply in Oregon, experiences of and response to fentanyl-involved overdose, and recommendations from PWUD to reduce overdose risk within the context of illicit fentanyl’s dramatic increase in the recreational drug supply over the past decade. METHODS: We conducted in-depth interviews by phone with 34 PWUD in Oregon from May to June of 2021. We used thematic analysis to analyze transcripts and construct themes. RESULTS: PWUD knew about fentanyl, expressed concern about fentanyl pills, and were aware of other illicit drugs containing fentanyl. Participants were aware of the increased risk of an overdose but remained reluctant to engage with professional first responders due to fear of arrest. Participants had recommendations for reducing fentanyl overdose risk, including increasing access to information, harm reduction supplies (e.g., naloxone, fentanyl test strips), and medications for opioid use disorder; establishing drug checking services and overdose prevention sites; legalizing and regulating the drug supply; and reducing stigma enacted by healthcare providers. CONCLUSION: PWUD in Oregon are aware of the rise of fentanyl and fentanyl pills and desire access to tools to reduce harm from fentanyl. As states in the Western USA face an inflection point of fentanyl in the drug supply, public health staff, behavioral health providers, and first responders can take action identified by the needs of PWUD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12954-022-00659-9. |
format | Online Article Text |
id | pubmed-9275036 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92750362022-07-13 “It wasn’t here, and now it is. It’s everywhere": fentanyl’s rising presence in Oregon’s drug supply Shin, Sarah S. LaForge, Kate Stack, Erin Pope, Justine Leichtling, Gillian Larsen, Jessica E. Leahy, Judith M. Seaman, Andrew Hoover, Daniel Chisholm, Laura Blazes, Christopher Baker, Robin Byers, Mikaela Branson, Katie Korthuis, P. Todd Harm Reduct J Research BACKGROUND: Illicit fentanyl has contributed to a drastic increase in overdose drug deaths. While fentanyl has subsumed the drug supply in the Northeastern and Midwestern USA, it has more recently reached the Western USA. For this study, we explored perspectives of people who use drugs (PWUD) on the changing drug supply in Oregon, experiences of and response to fentanyl-involved overdose, and recommendations from PWUD to reduce overdose risk within the context of illicit fentanyl’s dramatic increase in the recreational drug supply over the past decade. METHODS: We conducted in-depth interviews by phone with 34 PWUD in Oregon from May to June of 2021. We used thematic analysis to analyze transcripts and construct themes. RESULTS: PWUD knew about fentanyl, expressed concern about fentanyl pills, and were aware of other illicit drugs containing fentanyl. Participants were aware of the increased risk of an overdose but remained reluctant to engage with professional first responders due to fear of arrest. Participants had recommendations for reducing fentanyl overdose risk, including increasing access to information, harm reduction supplies (e.g., naloxone, fentanyl test strips), and medications for opioid use disorder; establishing drug checking services and overdose prevention sites; legalizing and regulating the drug supply; and reducing stigma enacted by healthcare providers. CONCLUSION: PWUD in Oregon are aware of the rise of fentanyl and fentanyl pills and desire access to tools to reduce harm from fentanyl. As states in the Western USA face an inflection point of fentanyl in the drug supply, public health staff, behavioral health providers, and first responders can take action identified by the needs of PWUD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12954-022-00659-9. BioMed Central 2022-07-11 /pmc/articles/PMC9275036/ /pubmed/35818072 http://dx.doi.org/10.1186/s12954-022-00659-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Shin, Sarah S. LaForge, Kate Stack, Erin Pope, Justine Leichtling, Gillian Larsen, Jessica E. Leahy, Judith M. Seaman, Andrew Hoover, Daniel Chisholm, Laura Blazes, Christopher Baker, Robin Byers, Mikaela Branson, Katie Korthuis, P. Todd “It wasn’t here, and now it is. It’s everywhere": fentanyl’s rising presence in Oregon’s drug supply |
title | “It wasn’t here, and now it is. It’s everywhere": fentanyl’s rising presence in Oregon’s drug supply |
title_full | “It wasn’t here, and now it is. It’s everywhere": fentanyl’s rising presence in Oregon’s drug supply |
title_fullStr | “It wasn’t here, and now it is. It’s everywhere": fentanyl’s rising presence in Oregon’s drug supply |
title_full_unstemmed | “It wasn’t here, and now it is. It’s everywhere": fentanyl’s rising presence in Oregon’s drug supply |
title_short | “It wasn’t here, and now it is. It’s everywhere": fentanyl’s rising presence in Oregon’s drug supply |
title_sort | “it wasn’t here, and now it is. it’s everywhere": fentanyl’s rising presence in oregon’s drug supply |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275036/ https://www.ncbi.nlm.nih.gov/pubmed/35818072 http://dx.doi.org/10.1186/s12954-022-00659-9 |
work_keys_str_mv | AT shinsarahs itwasnthereandnowitisitseverywherefentanylsrisingpresenceinoregonsdrugsupply AT laforgekate itwasnthereandnowitisitseverywherefentanylsrisingpresenceinoregonsdrugsupply AT stackerin itwasnthereandnowitisitseverywherefentanylsrisingpresenceinoregonsdrugsupply AT popejustine itwasnthereandnowitisitseverywherefentanylsrisingpresenceinoregonsdrugsupply AT leichtlinggillian itwasnthereandnowitisitseverywherefentanylsrisingpresenceinoregonsdrugsupply AT larsenjessicae itwasnthereandnowitisitseverywherefentanylsrisingpresenceinoregonsdrugsupply AT leahyjudithm itwasnthereandnowitisitseverywherefentanylsrisingpresenceinoregonsdrugsupply AT seamanandrew itwasnthereandnowitisitseverywherefentanylsrisingpresenceinoregonsdrugsupply AT hooverdaniel itwasnthereandnowitisitseverywherefentanylsrisingpresenceinoregonsdrugsupply AT chisholmlaura itwasnthereandnowitisitseverywherefentanylsrisingpresenceinoregonsdrugsupply AT blazeschristopher itwasnthereandnowitisitseverywherefentanylsrisingpresenceinoregonsdrugsupply AT bakerrobin itwasnthereandnowitisitseverywherefentanylsrisingpresenceinoregonsdrugsupply AT byersmikaela itwasnthereandnowitisitseverywherefentanylsrisingpresenceinoregonsdrugsupply AT bransonkatie itwasnthereandnowitisitseverywherefentanylsrisingpresenceinoregonsdrugsupply AT korthuisptodd itwasnthereandnowitisitseverywherefentanylsrisingpresenceinoregonsdrugsupply |